Kdl Biotech Profile
Key Indicators
- Authorised Capital ₹ 75.00 Cr
- Paid Up Capital ₹ 24.04 Cr
- Company Age 38 Year, 6 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 20.80 Cr
- Satisfied Charges ₹ 47.00 Cr
About Kdl Biotech
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24230MH1986PLC040603
- Company No.
040603
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Aug 1986
- Date of AGM
29 Sep 2012
- Date of Balance Sheet
31 Mar 2012
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kdl Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nalin Bamzai  | Managing Director | 22-Jun-2002 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Sinha  | Director | 18-Jul-2008 | Current |
| Rajesh Agrawal | Whole-Time Director | 26-Apr-2007 | Current |
| Avantika Varma | Additional Director | 17-Apr-2013 | Current |
Financial Performance of Kdl Biotech.
Enhance accessibility to Kdl Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kdl Biotech?
Unlock access to Kdl Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹20.80 Cr
₹47.00 Cr
Charges Breakdown by Lending Institutions
- Unimark Remedies Limited : 20.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Aug 2010 | Unimark Remedies Limited | ₹20.80 Cr | Open |
| 28 Jan 2004 | Chinatrust Commercial Bank | ₹4.00 Cr | Satisfied |
| 27 Mar 2000 | Industrial Investment Of Bank Of India Ltd | ₹15.00 Cr | Satisfied |
| 27 Mar 2000 | Central Bank Of India | ₹28.00 Cr | Satisfied |
How Many Employees Work at Kdl Biotech?
Unlock and access historical data on people associated with Kdl Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kdl Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kdl Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
